Peer-reviewed veterinary case report
Seresto collars stop Ehrlichia canis spread by ticks to dogs long-term
By Stanneck, Dorothee & Fourie, Josephus J·Published in Parasitology research·2013·Bayer Animal Health GmbH, Germany·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Imidacloprid 10 % / flumethrin 4.5 % collars (Seresto®, Bayer) successfully prevent long-term transmission of Ehrlichia canis by infected Rhipicephalus sanguineus ticks to dogs.
- Species:
- dog
Plain-English summary
A group of dogs wearing Seresto collars, which contain imidacloprid and flumethrin, were tested to see if they could prevent infection from ticks carrying Ehrlichia canis, a bacteria that can cause serious health issues. Over a long period, none of the dogs with the collars became infected, while a significant number of the dogs without collars did. The collars were highly effective at keeping ticks away, showing an efficacy rate of 90% to 100%. This suggests that using Seresto collars can be a reliable way to protect dogs from tick-borne diseases.
People also search for: dog tick prevention · Seresto collar effectiveness · Ehrlichia canis in dogs · how to protect dogs from ticks
Abstract
The objective of this study was to determine the empirical efficacy of imidacloprid 10 %/flumethrin 4.5 % (Seresto®) collars in preventing long-term transmission of Ehrlichia canis by infected Rhipicephalus sanguineus ticks to dogs. The study was a parallel group design, single centre, randomised, non-blinded, controlled, long-term efficacy study. The treatment group of 8 dogs was fitted with Seresto® collars, the untreated control group of 8 dogs received no collars. Ehrlichia canis-infected ticks were released into the dogs sleeping quarters at 14-day intervals up to Day +378. Control group dogs infected with E. canis were continuously replaced to keep the control sample size constant, and a total of 39 control dogs were required. The final clinical examination and blood sampling occurred on Day +420. The primary assessment criterion was the number of dogs infected with E. canis, as confirmed by IFA and PCR, and the secondary criterion was the acaricidal efficacy based on tick counts. All scheduled blood samples taken were subject to analyses for both PCR and IFA, but only positive cases are discussed. Up to Day +378, none of the collar-treated dogs were infected with E. canis, whereas 34 of the 35 untreated dogs enrolled before Day +371 were infected. The acaricidal efficacy of the collar ranged from 90 % to 100 % for the duration of the assessment period.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/23774841/